PTK2 and breast carcinoma: Further mechanistic study revealed FAK as a potential target of compound 4l in MDA-MB-231 breast cancer cells, and FAK inhibition appeared to be the mechanism underlying non-apoptotic cell death induction in 4l-treated cells.